Search

In Stock

Buy Isturisa (osilodrostat) Online

DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC)

MANUFACTURER: Novartis

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Isturisa (osilodrostat) is a cortisol synthesis inhibitor used to treat Cushing’s syndrome, a condition in which the body produces too much of the hormone cortisol. It is approved by the US Food and Drug Administration (FDA) for adults with Cushing’s disease, a type of Cushing’s syndrome caused by a tumor on the pituitary gland, and for adults with endogenous Cushing’s syndrome (ECS), a type of Cushing’s syndrome caused by the body overproducing cortisol on its own.

From $1,818.17

Clear
Compare

Isturisa (osilodrostat) is a cortisol synthesis inhibitor used to treat Cushing’s syndrome, a condition in which the body produces too much of the hormone cortisol. It is approved by the US Food and Drug Administration (FDA) for adults with Cushing’s disease, a type of Cushing’s syndrome caused by a tumor on the pituitary gland, and for adults with endogenous Cushing’s syndrome (ECS), a type of Cushing’s syndrome caused by the body overproducing cortisol on its own.

Description

Isturisa is a once-daily oral capsule that works by blocking the production of cortisol in the adrenal glands. It is available in three strengths: 1 mg, 2 mg, and 5 mg.

Uses

Isturisa is used to treat adults with Cushing’s disease and ECS. It can be used as a monotherapy or in combination with other treatments, such as surgery or radiation therapy.

Storage Conditions

Isturisa should be stored at room temperature (68°F to 77°F or 20°C to 25°C) in a dry place.

Mechanism of Action

Isturisa is a cortisol synthesis inhibitor. It works by blocking the production of cortisol in the adrenal glands. Cortisol is a hormone that is released in response to stress and helps the body to regulate blood sugar, blood pressure, and metabolism. Too much cortisol can cause a variety of health problems, including weight gain, high blood pressure, and diabetes.

How to Use

Isturisa is taken once daily with or without food. The starting dose is usually 1 mg. The dose may be increased or decreased by your doctor based on your response to treatment.

Important Safety Information

Isturisa can cause serious side effects, including:

  • Hypocortisolism (low cortisol levels): Hypocortisolism can cause a variety of symptoms, including fatigue, weakness, dizziness, low blood pressure, and nausea.
  • Adrenal insufficiency: Adrenal insufficiency is a condition in which the adrenal glands do not produce enough cortisol. It can be a life-threatening condition if not treated promptly.
  • QT interval prolongation: QT interval prolongation is a condition that can increase the risk of serious heart problems, such as arrhythmias.
  • Cushings syndrome recurrence: Isturisa does not cure Cushing’s syndrome. The condition can recur if treatment is stopped.

Indications

Isturisa is indicated for the treatment of adults with Cushing’s disease and ECS.

Precautions

Isturisa should be used with caution in patients with:

  • Hypocortisolism
  • Adrenal insufficiency
  • QT interval prolongation
  • Liver disease
  • Kidney disease
  • Pregnancy
  • Breastfeeding

Interactions

Isturisa can interact with other drugs, including:

  • CYP1A2 and CYP2C19 substrates: Isturisa can increase the blood levels of CYP1A2 and CYP2C19 substrates, such as theophylline, tizanidine, and S-mephenytoin.
  • CYP3A4 substrates: Isturisa can decrease the blood levels of CYP3A4 substrates, such as midazolam, triazolam, and alfentanil.
  • CYP2C9 substrates: Isturisa can increase the blood levels of CYP2C9 substrates, such as warfarin and phenytoin.

Contraindications

Isturisa is contraindicated in patients with:

  • Active adrenal insufficiency
  • Hypersensitivity to osilodrostat
  • Pregnancy
  • Breastfeeding

Overdose

An overdose of Isturisa can cause hypocortisolism. Symptoms of hypocortisolism include nausea, vomiting, fatigue, low blood pressure, abdominal pain, loss of appetite, dizziness, and syncope.

If you suspect an overdose of Isturisa, contact your doctor or go to the nearest emergency room immediately.

Side Effects

The most common side effects of Isturisa are:

  • Fatigue
  • Headache
  • Nausea
  • Diarrhea
  • Constipation
  • Dizziness
  • Decreased appetite
  • Weight loss

Other side effects of Isturisa can be more serious and include:

  • Hypocortisolism
  • Adrenal insufficiency
  • QT interval prolongation
  • Cushings syndrome recurrence

If you experience any side effects while taking Isturisa, be sure to talk to your doctor.

Package

60 tablets of 1 mg, 60 tablets of 5 mg, 60 tablets of 10 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Voxzogo (vosoritide) Online

$9,091.90
(0 Reviews)
DISEASE INDICATIONS: Achondroplasia MANUFACTURER: BioMarin Europe Ltd USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Voxzogo (vosoritide) is a prescription medicine used to increase linear growth in children with achondroplasia aged 5 years and older with open growth plates. Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth.

Buy Palynziq (pegvaliase-pqpz) Online

From $321.42
(0 Reviews)
DISEASE INDICATIONS: phenylketonuria (PKU) MANUFACTURER: BioMarin Pharmaceutical Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Palynziq (pegvaliase-pqpz) is a prescription medication used to lower blood levels of phenylalanine (Phe) in adults with phenylketonuria (PKU) who have uncontrolled blood Phe levels above 600 micromol/L (10 mg/dL) on their current treatment. PKU is a rare genetic disorder that prevents the body from breaking down the amino acid phenylalanine. Phenylalanine can build up in the blood and cause serious health problems, such as intellectual disability, seizures, and behavioral problems.

Buy Waylivra (volanesorsen) Online

$11,550.76
(0 Reviews)
DISEASE INDICATIONS: Familial chylomicronemia syndrome (FCS) MANUFACTURER: Akcea Therapeutics Ireland Limited USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Waylivra (volanesorsen) is a prescription medication used to treat adults with genetically confirmed familial chylomicronemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate. FCS is a rare genetic disorder that causes the body to produce too much of a type of fat called chylomicrons. Chylomicrons can build up in the blood and cause pancreatitis, a serious inflammation of the pancreas.

Buy Isturisa (osilodrostat) Online

From $1,818.17
(0 Reviews)
DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC) MANUFACTURER: Novartis USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Isturisa (osilodrostat) is a cortisol synthesis inhibitor used to treat Cushing's syndrome, a condition in which the body produces too much of the hormone cortisol. It is approved by the US Food and Drug Administration (FDA) for adults with Cushing's disease, a type of Cushing's syndrome caused by a tumor on the pituitary gland, and for adults with endogenous Cushing's syndrome (ECS), a type of Cushing's syndrome caused by the body overproducing cortisol on its own.

Buy Zokinvy (lonafarnib) Online

From $31,401.66
(0 Reviews)
DISEASE INDICATIONS: Progeria MANUFACTURER: Eiger Biopharmaceuticals USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Zokinvy (lonafarnib) is a prescription medication used to treat Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL) in children aged 12 months and older. HGPS and PDPL are rare genetic disorders that cause premature aging.

Buy Oxlumo (lumasiran) Online

$64,110.43
(0 Reviews)
DISEASE INDICATIONS: Primary hyperoxaluria type 1 (PH1) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Oxlumo (lumasiran) is a prescription medicine used to treat primary hyperoxaluria type 1 (PH1) in children and adults. PH1 is a rare genetic disorder that causes the body to produce too much of a substance called oxalate. Oxaluria can cause kidney stones, damage to the kidneys and other organs, and even death.

Buy Leqvio (inclisiran) Online

$2,671.00
(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Novartis USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Kerendia (finerenone) is a nonsteroidal mineralocorticoid receptor antagonist (MRA) approved by the US Food and Drug Administration (FDA) to reduce the risk of kidney failure, cardiovascular death, heart attack, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).

Back to Top
Product has been added to your cart